SPONSOR
Canadian Cancer Trials Group
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1, Phase 3
Conditions studied: Endometrial CancerAlveolar Soft Part SarcomaRenal Cell CarcinomaTriple Negative Breast CancerCancerPsychologicalProstate CancerHodgkin Lymphoma
Canadian Cancer Trials Group is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Endometrial Cancer, Alveolar Soft Part Sarcoma, Renal Cell Carcinoma, Triple Negative Breast Cancer.
The trial portfolio spans Phase 2, Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Canadian Cancer Trials Group
How many clinical trials has Canadian Cancer Trials Group sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Canadian Cancer Trials Group, of which 5 are actively recruiting participants. These trials cover conditions including Endometrial Cancer, Alveolar Soft Part Sarcoma, Renal Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Canadian Cancer Trials Group research focus on?
Canadian Cancer Trials Group clinical trials span Endometrial Cancer, Alveolar Soft Part Sarcoma, Renal Cell Carcinoma, Triple Negative Breast Cancer, Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Canadian Cancer Trials Group clinical trial?
To participate in a Canadian Cancer Trials Group trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Canadian Cancer Trials Group trials with current recruitment status updated daily.
Clinical Trials by Canadian Cancer Trials Group
NCT05640999 Phase 2
Recruiting
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Endometrial Cancer
NCT07297667 Phase 1
Recruiting
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Alveolar Soft Part Sarcoma
NCT05470010
Recruiting
Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors
Cancer
NCT06235697 Phase 3
Recruiting
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Prostate Cancer
NCT05180097 Phase 2
Recruiting
Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma
Hodgkin Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology